Please login to the form below

Not currently logged in
Email:
Password:

Parexel appoints chief scientific officer

Promotion for Sy Pretorius
Paraxel Sy Pretorius

Parexel has promoted Dr Sy Pretorius to the position of chief scientific officer.

Dr Pretorius currently serves as worldwide head of early phase development at the contract research organisation (CRO) and will continue in that role in addition to his new duties.

These responsibilities include enhancing and leading the innovation of clinical research methodologies and helping Parexel to meet client demands. Key priorities include clinical trial modelling and simulations and adaptive trial designs.

Dr Pretorius knows the needs of Parexel well have spent nearly 18 years at the company. During this time he has served in a variety of positions, including corporate VP, clinical pharmacology in North America.

Parexel's president and chief operating officer Mark Goldberg said: “Pretorius has enjoyed a long and distinguished career at the Company, and applying his expertise more broadly will benefit customers and Parexel alike."

30th May 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics